title: [Urology].
abstract: Two important expanded studies about the early detection of prostate cancer were made and give contradictory results. The American study didn't demonstrate any benefit on rate of survival, whereas the European one demonstrated 20% lower mortality, however with a non-negligible morbidity, and indubitable necessity of additional treatment. The PCA3 genetic test, praticed on urine after rectal touch, will allow in the future improving selection of patients with a pathological PSA for whom the first series of biopsies are negative, and where the question of further biopsies is still opened. The active observation of some prostate cancers (latent cancer) is a valuable therapeutic option, which, when done in an adequate manner, does not question the long term vital prognostic. The vitamines E and C as well the Selenium have no effect in preventing prostate cancer.
authors.affiliation: Centre de procréation médicalement assistée (CPMA), Vigie 5, 1003 Lausanne.
authors.forename: M
authors.initials: M
authors.lastname: Wisard
authors.forename: G
authors.initials: G
authors.lastname: Pescia
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy
chemical_list: D000951:Antigens, Neoplasm; D015415:Biomarkers; C479341:prostate cancer antigen 3, human; D017430:Prostate-Specific Antigen